Company · CIK 1885827 # Virax Biolabs Group Ltd | CIK | [1885827](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001885827) (SEC EDGAR) | | --- | --- | | Industry (SIC) | 2835 — In Vitro & In Vivo Diagnostic Substances | | Incorporated in | E9 | | Business address | United Kingdom | | Listed | VRAX (Nasdaq) | | First annual or quarterly report | 2022-08-12 | ## Offerings 6 registrations | Registration | Label and status | First filed | Last event | Filings | | --- | --- | --- | --- | --- | | 333-275893 | Shelf Effective | 2023-12-05 | 2026-09-04 | 6 | | 333-297684 | Shelf Effective | 2026-07-24 | 2026-09-03 | 2 | | 333-292241 | Shelf Effective | 2025-12-18 | 2025-12-30 | 2 | | 333-270734 | Registered company Effective | 2023-03-22 | 2023-03-30 | 2 | | 333-268486 | Registered company Effective | 2022-11-21 | 2022-12-01 | 2 | | 333-263694 | IPO Final prospectus | 2022-03-18 | 2022-07-21 | 9 | ## Filings 24 | Filed | Filing | Registration | Accession | | --- | --- | --- | --- | | 2026-09-04 | [424B5](https://www.sec.gov/Archives/edgar/data/1885827/000119312526383658/0001193125-26-383658-index.htm) Shelf takedown | 333-275893 | 0001193125-26-383658 | | 2026-09-03 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1885827/999999999526002878/9999999995-26-002878-index.htm) Declared effective | 333-297684 | 9999999995-26-002878 | | 2026-07-24 | [F-3](https://www.sec.gov/Archives/edgar/data/1885827/000119312526316130/0001193125-26-316130-index.htm) Shelf registered | 333-297684 | 0001193125-26-316130 | | 2025-12-30 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1885827/999999999525003963/9999999995-25-003963-index.htm) Declared effective | 333-292241 | 9999999995-25-003963 | | 2025-12-18 | [F-3](https://www.sec.gov/Archives/edgar/data/1885827/000119312525324805/0001193125-25-324805-index.htm) Shelf registered | 333-292241 | 0001193125-25-324805 | | 2024-09-30 | [424B5](https://www.sec.gov/Archives/edgar/data/1885827/000095017024110179/0000950170-24-110179-index.htm) Shelf takedown | 333-275893 | 0000950170-24-110179 | | 2024-08-23 | [424B5](https://www.sec.gov/Archives/edgar/data/1885827/000095017024100026/0000950170-24-100026-index.htm) Shelf takedown | 333-275893 | 0000950170-24-100026 | | 2024-01-22 | [424B5](https://www.sec.gov/Archives/edgar/data/1885827/000095017024006155/0000950170-24-006155-index.htm) Shelf takedown | 333-275893 | 0000950170-24-006155 | | 2023-12-15 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1885827/999999999523003660/9999999995-23-003660-index.htm) Declared effective | 333-275893 | 9999999995-23-003660 | | 2023-12-05 | [F-3](https://www.sec.gov/Archives/edgar/data/1885827/000095017023068150/0000950170-23-068150-index.htm) Shelf registered | 333-275893 | 0000950170-23-068150 | | 2023-03-30 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1885827/999999999523000763/9999999995-23-000763-index.htm) Declared effective | 333-270734 | 9999999995-23-000763 | | 2023-03-22 | [F-1](https://www.sec.gov/Archives/edgar/data/1885827/000095012323002979/0000950123-23-002979-index.htm) Registration filed | 333-270734 | 0000950123-23-002979 | | 2022-12-01 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1885827/999999999522003433/9999999995-22-003433-index.htm) Declared effective | 333-268486 | 9999999995-22-003433 | | 2022-11-21 | [F-1](https://www.sec.gov/Archives/edgar/data/1885827/000119312522289176/0001193125-22-289176-index.htm) Registration filed | 333-268486 | 0001193125-22-289176 | | 2022-07-21 | [424B4](https://www.sec.gov/Archives/edgar/data/1885827/000121390022040585/0001213900-22-040585-index.htm) Final prospectus | 333-263694 | 0001213900-22-040585 | | 2022-06-30 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1885827/999999999522001935/9999999995-22-001935-index.htm) Declared effective | 333-263694 | 9999999995-22-001935 | | 2022-06-27 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1885827/000121390022035012/0001213900-22-035012-index.htm) Amendment | 333-263694 | 0001213900-22-035012 | | 2022-06-24 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1885827/000121390022034730/0001213900-22-034730-index.htm) Amendment | 333-263694 | 0001213900-22-034730 | | 2022-06-21 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1885827/000121390022033728/0001213900-22-033728-index.htm) Amendment | 333-263694 | 0001213900-22-033728 | | 2022-06-07 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1885827/000121390022031420/0001213900-22-031420-index.htm) Amendment | 333-263694 | 0001213900-22-031420 | | 2022-05-11 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1885827/000121390022025539/0001213900-22-025539-index.htm) Amendment | 333-263694 | 0001213900-22-025539 | | 2022-04-25 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1885827/000121390022021214/0001213900-22-021214-index.htm) Amendment | 333-263694 | 0001213900-22-021214 | | 2022-03-18 | [F-1](https://www.sec.gov/Archives/edgar/data/1885827/000121390022013563/0001213900-22-013563-index.htm) Registration filed | 333-263694 | 0001213900-22-013563 | | 2021-12-27 | [DRS](https://www.sec.gov/Archives/edgar/data/1885827/000121390021067581/0001213900-21-067581-index.htm) Draft made public | 377-05887 | 0001213900-21-067581 | [All filings of this company](https://equitycapital.markets/filings?cik=1885827) · [CSV](https://equitycapital.markets/filings.csv?cik=1885827) --- Source page: https://equitycapital.markets/company/1885827 · Data: U.S. SEC EDGAR · CC BY 4.0